Clinical trials
Terminated Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| Masonic Cancer Center, University of Minnesota | 4 |
| Incyte Corporation | 2 |
| University of California, San Francisco | 2 |
| Wake Forest University Health Sciences | 2 |
| Alison Walker | 1 |
| Brown University | 1 |
| CTI BioPharma | 1 |
| City of Hope Medical Center | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 46 |
| Leukemia, Myeloid, Acute | 27 |
| Myelodysplastic Syndromes | 25 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 20 |
| Leukemia | 19 |
| Anemia, Refractory | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 14 |
| Leukemia, Myelomonocytic, Chronic | 14 |
| Hodgkin Disease | 13 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 13 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.